- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
Anonymous complaint about alleged promotion of Levitra by Bayer. PMCPA recorded the matter as outwith the scope of the Code; no case…
GSK was found in breach for misleading “efficacy in 3 steps: Open Inhale Close” claims in Relvar digital sales aids and for…
Ferring agreed in inter-company dialogue to withdraw a Cortiment leavepiece but it was still used at a conference weeks later. Panel found…
PMCPA ruled Vifor breached undertakings by using materials and a medical information email that misleadingly compared Ferinject vs Monofer on hypersensitivity/ADRs, and…
Eliquis promotional email used July 2019 prescribing information after an Oct 2019 SPC update on reversal agent/overdose. Panel found PI content sufficient…
A UK health professional said DuoResp Spiromax prescribing information in a Teva-commissioned webinar was difficult to read. The Panel ruled the line…
A UK health professional said a Duac online banner appeared static and lacked a one-click link to prescribing information. Panel found PI…
Anonymous complaint about an unsolicited MSL email to an NHS address during COVID-19. Panel found the email was non-promotional, mirrored an approved…
A health professional received a promotional Parkinson’s magazine by email despite asking to be removed from mailing lists. PMCPA found breaches for…
A UK health professional alleged a Praluent website banner broadened the licence and promoted off-label. The PMCPA Panel found the claim aligned…
A melanoma patient booklet was found balanced on treatment/testing, but breached the Code because “in association with” Melanoma UK was ambiguous and…
UK employees ‘liked’ a US colleague’s LinkedIn post about positive Opdivo Phase 3 data in upper GI cancers. The Panel said this…
RCGP Overdiagnosis Group challenged a Pfizer/BMS Eliquis email promoting AF pulse checks at flu clinics for over-65s, alleging omission of UK NSC…
A Novartis employee ‘liked’ a Cosentyx study headline on LinkedIn. PMCPA ruled POM promotion to the public plus missing INN and certification…
Ever Pharma challenged Britannia’s use of an 0844 business-rate number for APO-go support. Panel found the helpline was in scope but ruled…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.